RUA: Q1 FY25 sales surged, export channels expanded, and a capital raise is planned for further growth

About this update from Rua Bioscience Ltd.

Q1 FY25 sales more than doubled FY24's total, driven by export growth in Germany and Australia. Despite going concern uncertainties, operational flexibility and a planned capital raise position the business for continued expansion and entry into the UK market.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Rua Bioscience Ltd.